in a gradient ethanol series and infiltrated with Epon812. The samples were embedded and cured at 37°C for 12 h, 45°C for 12 h and 60°C for 24 h. Ultrathin sections were cut using Leica EM UC7 and uranyl acetate and lead citrate were used to stain the section before the observation.
Histological Experiments:
Tumors from nude mice were excised. The tissues were fixed in 10% formaldehyde and embedded in paraffin. Then the paraffin masses were cut and dewaxed. The sections were dehydrated using graded ethanol series and washed by distilled water. The tumor sections were stained with hematoxylin and eosion to observe the tumor tissue structure. Immunofluorescence staining followed the dehydration. After being treated with Trition X-100 and serum, the sections were stained by Ki-67 (D3B5) Rabbit mAb (Alexa Fluor® 647 Conjugate) (Cell Signaling Technology, USA) overnight. The sections were stained by DAPI to display the nucleus and enveloped by glycerol before observation. The TUNEL experiments were carried out according DeadEnd™ Colorimetric Apoptosis Detection System (Promega, USA).
Establishment of the HepG2 and HepG2/DDP Transplanted Tumor Nude Mice: 5-week-old specific pathogen free nude mice were provided by Changzhou Cavens Lab Animal Co. Ltd. The animals were housed in individual ventilated cages and fed a SPF laboratory diet and water ad libitum. 2 × 10 6 cells were suspended in media and implanted subcutaneously into nude mice. HepG2 and HepG2/DDP xenografts were established in nude mice until the tumor volumes typically reached to about 200 mm 3 . All experiments were performed in accordance with the guidelines established by the Committee of Animal Research Policy of Binzhou Medical University.
HepG2 and HepG2/DDP Xenografts Treatments: 1) Chemotherapy Treatment: When the tumor size reached 200 mm 3 , DDP (0.5 mg/mL × 0.5 mL) was given by intraperitoneal injection (i.p.) every other day.
2) Hypothermia Treatment: Anesthesia with isoflurane inhalation was firstly administrated. Then the tumor temperature was decreased to 32 -34 o C by ice pack onto the tumors of nude mice for 1 h every other day. Infrared thermometer was used to monitor the tumor temperature.
3) Chemotherapy + Hypothermia Treatment: When the tumor size reached 200 mm 3 , DDP (0.5 mg/mL × 0.5 mL, i.p.) was given every other day. Anesthesia with isoflurane inhalation was administrated to immobilize the mouse at 1 h after the injection. The tumor temperature was decreased to 32 -34 o C by ice pack onto the tumors of nude mice for 1 h. Infrared thermometer was used to monitor the tumor temperature.
4) Hyperthermia Treatment:
Anesthesia with isoflurane inhalation was firstly administrated. A microwave device was employed to process the hyperthermia therapy above the tumor 3 cm every other day. The therapy needs a frequency of 2450 MHz microwave and a therapeutic diameter of 8 cm. The skin of tumor should be kept at 42 o C for 1 h. Infrared thermometer was used to monitor the tumor temperature.
5) Chemotherapy + Hyperthermia Treatment:
When the tumor size reached 200 mm 3 , DDP (0.5 mg/mL × 0.5 mL, i.p.) was given every other day. Anesthesia with isoflurane inhalation was administrated to immobilize the mouse at 1 h after the injection. A microwave device was employed to process the hyperthermia therapy above the tumor 3 cm every other day. The therapy needs a frequency of 2450 MHz microwave and a therapeutic diameter of 8 cm. The skin of tumor should be kept at 42 o C for 1 h. Infrared thermometer was used to monitor the tumor temperature.
6) Triple Therapeutics
ⅰ) GSH + Chemotherapy + Hypothermia Treatment: The nude mice were given GSH (0.13 mg/mL × 0.1 mL) by tail vein injection before the Chemotherapy + Hypothermia Treatment ⅱ) GSH + Chemotherapy + Hyperthermia Treatment: The nude mice were given GSH (0.13 mg/mL × 0.1 mL) by tail vein injection before the Chemotherapy + Hyperthermia Treatment Imaging Mice in vivo: A Bruker In-vivo Imaging System was employed to image tumor bearing nude mice. The excitation and emission wavelengths were chosen as described in paper. The mice were anesthetized prior to injection and during imaging. After in vivo imaging, the organs (lung, heart, liver, kidney and spleen) and tumors were excised to perform ex vivo imaging.
Statistical Analysis: Statistical Product and Service Solutions (SPSS) software 19.0 was used for the statistical analysis. The error bars shown in the figures represented the mean ± s.d. Differences were determined with a oneway, two-way analysis of variance (ANOVA) followed by LSD test. Statistical significance was assigned at  P < 0.05,  P < 0.01. Sample size was chosen empirically based on our previous experiences and pre-test results. No statistical method was used to predetermine sample size and no data were excluded. The numbers of animals or samples in every group were described in the corresponding figure legends. The distributions of the data were normal. All experiments were done with at least three biological replicates. Experimental groups were balanced in terms of animal age, sex and weight. Animals were all caged together and treated in the same way. Appropriate tests were chosen according to the data distribution. Variance was comparable between groups in experiments described throughout the manuscript.
Synthesis and Characterization of Compounds
Scheme S1. Synthetic routes for probe CyO-Dise. 4 The mixture was suspended at 0 o C, then 1 mL DIPEA was added. The reaction lasted for 30 min, and the color of the solution changed into green from red. After removed solvent in vacuum, the obtained residue was dissolved in 50 mL anhydrous CH 2 Cl 2 , and added DIPEA (1 mL) and DMAP (20 mg). bis(2-hydroxyethyl) diselenide (50.0 mg, 0.2 mmol) in CH 2 Cl 2 (2 mL) was added into above mixture, 5 then the reaction mixture was stirred at 25 °C, TLC monitored the reaction until the starting material was completely consumed. The obtained solid residue was purified through a silica gel chromatography (200 -300 mesh) with gradient eluent of CH 2 Cl 2 and CH 3 OH (100:0 to 85:15 v/v). The solvent was removed in vacuum, and the obtained solid was dissolved in CH 2 Cl 2 , filtered and evaporated to give a green solid (122 mg, yield 87%). The green solid (84.2 mg, 0.06 mmol) and potassium carbonate (1.2 mL from a 0.5 M solution in MeOH) were added in anhydrous MeOH (5 mL). The reaction mixture was stirred at 25 °C for 1 h. After neutralized with diluted hydrochloric acid (5%), the solution was extracted with CH 2 Cl 2 (3 × 50 mL). The organic layer was dried with anhydrous Na 2 SO 4 .
After concentrated under vacuum, the crude solid was purified by column chromatography (200 -300 mesh) using CH 2 Cl 2 : CH 3 OH (8:1 v/v) as eluent to obtain CyO-Dise as green solid (45 mg, 61% 
Spectral Properties and Selectivity of CyO-Dise
The spectroscopic properties of the probe CyO-Dise was investigated under simulated physiological conditions (10 mM HEPES, pH 7.4). There existed a linear relationship between logarithm of the ratio (F 615 nm /F 785 nm ) and the concentrations of GSH (Fig. S1d) . The regression equation was Lg(F 615 nm /F 785 nm ) = 0.1703 [GSH] mM -0.6096, with r = 0.9947. The experimental detection limit was determined to be 50 μM. The theoretical detection limit was calculated to be as low as 20 μM (3σ/k), where σ was the standard deviation of blank measurement, and k was the slope of regression equation. Considering the rapid metabolism unstable nature of GSH, the reaction kinetics of CyO-Dise towards GSH was performed to inspect whether the probe could selectively fast respond to GSH. It should be emphasized that diselenide had been used to response cysteine persulfide (Cys-SSH). However, these two kinds of reactive sulfur species are not at an order of magnitude in living cells. The concentrations of Cys-SSH are at micromolar levels, 5 while the concentrations of GSH are at millimolar levels concentrations. 6, 7 So, Cys-SSH would not lead to big interference in the GSH detection. Other biothiols including Cys-SSH, hydrogen sulfide (H 2 S, provided as NaSH), cysteine (Cys), homocysteine (HCy) were also investigated their reaction kinetic with the probe. GSH and the other biothiols were respectively added at 10 s, and then the ratio-fluorescent signal response were recorded during 0 -80 s. GSH induced ratio-fluorescent changes and reached saturation within 35 s. Cys-SSH also induce the ratiofluorescent changes within 20 s. However, Cys-SSH could not consume all the probe. Other biothiols induced negligible ratio-fluorescent signal changes (Fig. S1e) . Moreover, we investigated whether the present of biothiols could affect the detection of GSH. Exposing CyO-Dise to a mixture of biothiols and GSH almost yielded the same ratio-fluorescence enhancement as that only treated with GSH (Fig. S1e) . The results may contribute to the higher concentration of GSH in biological organism than the other biothiols. The reaction kinetics studies indicated that our probe could be used as a real-time bioimaging tool for intracellular GSH without the interference of biothiols .
Our next efforts were made to test and verify selectivity of CyO-Dise towards GSH. All the tests lasted 50 s. Upon exposed to various analytes in HEPES (10 mM, pH 7.4), the probe CyO-Dise selectively exhibited excellent ratio fluorescence response to GSH. Other biothols (such as Cys-SSH, NaSH, Cys, Hcy), selenocysteine, ascorbic acid, thioredoxin reductase (TrxR), N-acetyl-L-cysteine and various amino acids (AAs) induced negligible interference (Fig. S1f) . Reactive oxygen species, reactive nitrogen species, anions and metal ions couldn't cause any spectral changes ( Fig. S2a and S2b) . All the results demonstrated that CyO-Dise could selectively detect GSH without interference by other species. The detailed reaction pathway of the exchange reaction through intramolecular cyclization reaction were explored by performing molecular dynamics (MD) simulation and first-principles quantum mechanical/molecular mechanical free energy (QM/MM-FE) calculations. 8 The geometry of all molecular structures were optimized at the HF/6-31G* level using Gaussian03. 9 The QM calculations were performed with the B3LYP functional, and the MM calculations were conducted by using a modified version of AMBER. 10 Given in parentheses are the relative free energies with the zero-point and thermal corrections for the QM subsystem. The QM/MM-FE calculations for all QM/MM-optimized geometries along the reaction path were performed at the B3LYP/6-31++G**: AMBER level. In order to simplify the molecular structure optimization and calculation processes, we replaced the galactoseterminated ligand as methoxy (Scheme S2).
Evaluation the Detailed Free Energy Barrier of the Activation Processes

Effect of pH Values and Temperature Fluctuations to CyO-Dise and CyO
Standard fluorescence pH titrations were performed in 10 mM HEPES solution at a concentration of 10 μM (CyO-Dise and CyO). As shown in Fig. S3a and 3b , the pH of the media hardly effected on fluorescence intensity within the range from 3.0 to 10.0. On this basis, we suggested that CyO-Dise would work well under physiological conditions (pH = 7.4). Standard fluorescence temperature titrations were performed in 10 mM HEPES solution at a concentration of 10 μM (CyO-Dise and CyO). As shown in Fig. S3c and 3d , the temperature of the mediums hardly effected on fluorescence intensity within the range from 4 °C to 44 °C. On this basis, we suggested that CyO-Dise would work well under physiological conditions (pH = 7.4). 
Reaction Kinetics of CyO-Dise towards GSH
Reaction Mechanism Discussion between Probe CyO-Dise and GSH
We had described the reaction mechanism in Scheme 1, the reduction of diselenide immediately formed an intermediate (CyO-SeH). Then a fast intramolecular cyclization occurred by cleavage of neighboring ester bond to release CyO. This proposed reaction mechanism was verified by HRMS, as shown in Fig. S6 Scheme S3. The possible reaction mechanism between probe CyO-Dise and GSH.
MTT Assay for CyO-Dise
To access the potential toxicity of CyO-Dise, MTT assays were carried out. HepG2 cells (10 6 cells/mL) and HL-7702 cells (10 6 cells/mL) were planted into 96-well microtiter plates in DMEM or RPMI 1640 with 10% fetal bovine serum (FBS). Plates were maintained at 37 °C in a 5% CO 2 /95% air incubator for 24 h. Then the cells were incubated for 24 h at 37 °C in a 5% CO 2 /95% air upon different concentrations probe of 0 μM to 100 μM respectively. MTT solution (5.0 mg/mL, PBS) was then added to each well. After 4 h, the remaining MTT solution was removed, and 200 μL of DMSO was added to each well, shaking 10 min to dissolve the formazan crystals at room temperature. Absorbance was measured at 490 nm in a TECAN infinite M200pro microplate reader. Fig. 1 Measured by CyO-Dise through Cell Imaging Experiments Table S1 GSH concentrations in Fig. 1 measured by CyO-Dise through cell imaging experiments. Fig. 1 Measured by CyO-Dise through Flow Cytometry Analysis Table S2 GSH concentrations in Fig. 1 measured by CyO-Dise through flow cytometry analysis. Fig. 1 
GSH concentrations in
measured by Total Glutathione Assay Kit
The GSH concentrations in Fig. 1 were further measured by Total Glutathione Assay Kit (Beyotime, China). The total GSH concentrations were shown in Table S3 , which was consistent with our probe analysis results. Fig. 2 Fig. 2k 
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Determination the IC 50 of HepG2/DDP to DDP with MTT assay
HepG2/DDP cells (5 × 10 4 cells/mL) were seeded in 96-well microplates, at 100 μl/well and cultured overnight to allow cell adherence. Then, gradient concentrations of DDP (0, 20, 40, 60, 80, 100, 120, 140, 160, 180, 200, 220, 240, 260, 280, 300 μM) were added and the cells were further cultured for 72 h. Next, 50 μl MTT was added in accordance with the reagent instructions and cultured for 4 h. The optical density (OD) was measured at 490 nm wavelength with a TECAN infinite M200pro microplate reader. The inhibition rate of the drug on the cells was calculated as follows:
Using the DDP concentration as abscissa and the inhibition rate as ordinate, the inhibition curves were plotted and fitted to obtain the half maximal inhibitory concentrations (IC 50 ). 
Evaluation of GSH Effiency in
Fluorescent Recovery Assay
We performed the cell imaging experiments to check the fluorescence recovery. The cells were treated with 5 mM NEM for 30 min to consume all the GSH. And then 5 mM GSH monoethyl ester (GSH-MEE) were added for 2 h as exogenous GSH supplement. 11, 12 Hypothermia (4 o C and 30 o C) and hyperthermia (42 o C and 44 o C) were carried out for 30 min, respectively. As shown in Fig. S26a , the ratio-fluorescent intensity signals recovered after the addition of GSH-MEE. The cell imaging experiments indicated that probe CyO-Dise could capture the fluorescence recovery from exogenous addition of GSH-MEE. And flow cytometry analysis was carried out to verify the above results (Fig. S26b) . The flow cytometry analysis results were consisted with pseudo-color ratio images results. The average fluorescence intensities of CyO-Dise upon addition of GSH-MEE in Fig. 26a and the corresponding mean ratio intensities in Fig. 26b were further shown in Fig. 26c and Fig. 26d . After calculations using the regression equation in Fig. S1d , we obtained concentrations of GSH in HL-7702 and HepG2 cells, respectively (Table S7 and S8). All the results revealed that the probe CyO-Dise could be used as a facilitative tool to directly image GSH recovery in living cells. 
HPLC Data for Quantification GSH Levels
To check the authenticity and accuracy of the quantification results, we further performed high-performance liquid chromatography (HPLC) experiments. 5,5'-dithio-bis-nitrobenzoic acid (DTNB) was introduced as precolumn derivatization reagent as shown in Scheme S4.
The cultured HepG2, HL-7702 cells and HepG2/DDP were treated as described and then washed with PBS buffer twice. After centrifugation and removal of supernatant liquid, the resulting cells were stored at -80°C for 5 min. After thawing to room temperature, the cells were lysed by hyperacoustic in 1 mL lysis buffer (PBS with 0.1% Triton X-100, pH 7.4) and the supernatant liquid was collected after centrifugation (10,000 × g, 10 min, 4 °C). The derivatization reaction was realized utilizing 100 μL of the cells supernatant, 500 μL of Tris-HCl buffer 0.5 M, pH 8.9 and 300 μL of DTNB 10 mM in of K 2 HPO 4 0.5 M, pH 8.0. After 5 min in an ice bath, was acidified by addition of 100 μL H 3 PO 4 7 M and centrifuged at 3000× g for 10 min. 13 Then, derivatized samples were filtered through a 0.22 μm membrane for HPLC analysis. The derivatized samples were separated on RP-HPLC with a ZORBAX SB-C18 column (4.6 × 150 mm, 5 μm). Mobile phase A consisted of 12% methanol (v/v), 100 mM KH 2 PO 4 , pH 3.8 at a flow rate of 0.8 mL/min. Mobile phase B consisted of 40% methanol(v/v), 100 mM KH 2 PO 4 , pH 3.8 at a flow rate of 0.8 mL/min. 14 GSH-DTNB was detected by UV absorbance at 330 nm. The column temperature was 37°C, and the injection volume was 20 µL.
GSH standards (2 mM, 4 mM, 6 mM, 8 mM and10 mM) were selected to perform HPLC analysis (Fig. S27a) . Retention time of GSH-DTNB was 11.13 min. There existed a linear relationship between peak area and the concentrations of GSH (Fig. S27b) . The regression equation was Area = 36. 5 [GSH] mM -46.2, with r = 0.9937. HPLC analysis of GSH concentrations in Fig.1 and Fig.S26 were shown in Table S9 . The GSH level changes in Fig.2 and Fig.S14 were demonstrated in Table S10. Table S11 revealed the accurate GSH concentration fluctuations in Fig.3 and Fig.S22 . Scheme S4. The derivative reaction between GSH and DTNB. Fig.1 and Fig.S26 .
Table S10 HPLC analysis of GSH concentrations in Fig.2 and Fig.S14 . Table S11 HPLC analysis of GSH concentrations in Fig.3 and Fig.S22 .
